Lung Cancer Awareness Monthly

Nine statements developed, including performing four or more versus three or fewer needle passes in suspected malignant disease

Better outcomes also seen for dyspnea compared with controls

Significantly longer overall and progression-free survival seen among patients with limited-stage small cell lung cancer

Study shows similar effects on quality of life as in-person visits

Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5

Perioperative nivolumab showed event-free survival benefit from time of surgery compared with neoadjuvant nivolumab

Having two or more alternative explanation conditions delays lung cancer diagnosis by 74 days

After adjustment for baseline cardiovascular risk, pulmonary vein volume receiving 5 Gy linked to atrial fibrillation

Alternative criteria included people who smoked any amount for at least 40 years; people aged 60 to 80 years with 40 pack-years of smoking

Rheumatoid arthritis-interstitial lung disease shows particularly high risk